ArticleBMC gastroenterology2026
Development and internal validation of a clinical-CT model for differentiating intestinal-type from pancreatobiliary-type periampullary carcinoma.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundIntestinal-type and pancreatobiliary-type periampullary carcinomas exhibit distinct biological behaviours and prognostic outcomes, yet accurate preoperative subtyping remains a major clinical challenge. This study aimed to evaluate the value of clinical variables and computed tomography (CT) imaging features in the differential diagnosis of intestinal-type and pancreatobiliary-type periampullary carcinoma, and to develop a subtype prediction model.
methodsThis retrospective study included 83 patients with pathologically confirmed periampullary carcinoma, comprising 21 intestinal-type and 62 pancreatobiliary-type periampullary carcinomas. Clinical variables and conventional CT imaging features were evaluated using univariable and multivariable logistic regression analyses to identify predictors associated with PAC subtype. Based on these predictors, clinical, radiologic, and combined prediction models were developed, and a nomogram was constructed from the combined model. Model performance was evaluated using receiver operating characteristic (ROC) curves and the area under the curve (AUC). The DeLong test was employed to compare the diagnostic performance among different models.
resultsThe AUCs of the clinical model and radiologic model were 0.82 (95%CI, 0.70-0.92) and 0.85 (95%CI, 0.79-0.93), respectively. The combined model showed significantly better diagnostic performance than either model alone, with an AUC of 0.92 (95%CI, 0.84-0.97), a sensitivity of 87.1%, and a specificity of 90.5%. Serum carbohydrate antigen 19 - 9, total bilirubin, tumor location, and enhancement degree of lesion were identified as the most important predictors in the combined model. In addition, the nomogram derived from the combined model demonstrated good discriminative ability for predicting histologic subtype.
conclusionThe combined model integrating clinical and CT imaging features enables more accurate preoperative differentiation between intestinal-type and pancreatobiliary-type periampullary carcinoma and yields higher sensitivity and specificity than models based on clinical or imaging features alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.